|
| 37791942 | Long-Term Outcomes Following Fairly Brief Androgen Suppression and Stereotactic Radiation Therapy in High-Risk Prostate Cancer: Update From the FASTR/FASTR-2 Trials. | Pract Radiat Oncol | 2024 |
| 36641305 | Validation of a surface-based deformable MRI-3D ultrasound image registration algorithm toward clinical implementation for interstitial prostate brachytherapy. | Brachytherapy | 2023 |
| 37581539 | <sup>18</sup>F-DCFPyL PSMA-PET affects management of salvage radiotherapy for post-prostatectomy patients with biochemical failure: A matched cohort study. | Can Urol Assoc J | 2023 |
| 35440642 | The impact of PSMA PET on the treatment and outcomes of men with biochemical recurrence of prostate cancer: a systematic review and meta-analysis. | Prostate Cancer Prostatic Dis | 2023 |
| 37126232 | Multimodal Biomarkers That Predict the Presence of Gleason Pattern 4: Potential Impact for Active Surveillance. | J Urol | 2023 |
| 37124027 | Planning for the Effect of the SC.24 Trial on Spine Stereotactic Body Radiation Therapy Utilization at a Tertiary Cancer Center. | Adv Radiat Oncol | 2023 |
| 37350543 | What's to come in PSMA therapies and diagnostics: A summary of clinical trials involving PSMA radioligand-based therapeutic and/or diagnostic approaches with active recruitment. | Expert Rev Anticancer Ther | 2023 |
| 37081426 | The use of Lutetium-177 PSMA radioligand therapy with high dose rate brachytherapy for locally recurrent prostate cancer after previous definitive radiation therapy: a randomized, single-institution, phase I/II study (ROADSTER). | BMC Cancer | 2023 |
| 37008255 | Proton Radiotherapy for Management of Medulloblastoma: A Systematic Review of Clinical Outcomes. | Adv Radiat Oncol | 2023 |
| 34506217 | Prevalence and Workplace Drivers of Burnout in Cancer Care Physicians in Ontario, Canada. | JCO Oncol Pract | 2022 |
| 35733492 | An Electronic Information Kiosk for Enhancing Patient Accrual for Cancer Clinical Trials: A Pilot and Feasibility Study. | Cureus | 2022 |
| 35643253 | Stereotactic Radiation for the Comprehensive Treatment of Oligometastases (SABR-COMET): Extended Long-Term Outcomes. | Int J Radiat Oncol Biol Phys | 2022 |
| 35608445 | Impact of <sup>18</sup>F-DCFPyL PET on Staging and Treatment of Unfavorable Intermediate or High-Risk Prostate Cancer. | Radiology | 2022 |
| 35494042 | Imaging Biomarkers in Prostate Stereotactic Body Radiotherapy: A Review and Clinical Trial Protocol. | Front Oncol | 2022 |
| 35690353 | Can We Identify Predictors of Success in Contouring Education for Radiation Oncology Trainees? An Analysis of the Anatomy and Radiology Contouring Bootcamp. | Pract Radiat Oncol | 2022 |
| 36095953 | Prostate cancer classification using radiomics and machine learning on mp-MRI validated using co-registered histology. | Eur J Radiol | 2022 |
| 36353652 | Does brachytherapy boost improve survival outcomes in Gleason Grade Group 5 patients treated with external beam radiotherapy and androgen deprivation therapy? A systematic review and meta-analysis. | Clin Transl Radiat Oncol | 2022 |
| 36395792 | PSMA PET- and mpMRI-directed Prostate Cancer Salvage. | Int J Radiat Oncol Biol Phys | 2022 |
| 35076300 | Effect of <sup>18</sup>F-DCFPyL PET/CT on the Management of Patients with Recurrent Prostate Cancer: Results of a Prospective Multicenter Registry Trial. | Radiology | 2022 |
| 35269620 | On the Way for Patients with Prostate Cancer to the Best Use of PSMA. | Int J Mol Sci | 2022 |
| 35337747 | Targeting prostate lesions on multiparametric MRI with HDR brachytherapy: Optimal planning margins determined using whole-mount digital histology. | Brachytherapy | 2022 |
| 34991634 | A pilot study of machine-learning based automated planning for primary brain tumours. | Radiat Oncol | 2022 |
| 35260100 | PSMA PET/CT guided intensification of therapy in patients at risk of advanced prostate cancer (PATRON): a pragmatic phase III randomized controlled trial. | BMC Cancer | 2022 |
| 34710522 | Is Remote Learning as Effective as In-Person Learning for Contouring Education? A Prospective Comparison of Face-to-Face versus Online Delivery of the Anatomy and Radiology Contouring Bootcamp. | Int J Radiat Oncol Biol Phys | 2022 |
| 32891558 | American Society for Radiation Oncology Editorial: Rapidly Evolving Technologies Related to Imaging Strategies for Advanced Prostate Cancer. | Pract Radiat Oncol | 2021 |
| 33853550 | Ablative radiation therapy to restrain everything safely treatable (ARREST): study protocol for a phase I trial treating polymetastatic cancer with stereotactic radiotherapy. | BMC Cancer | 2021 |
| 33714523 | "All the Better to Treat You With⿦". | Int J Radiat Oncol Biol Phys | 2021 |
| 33648893 | A multiobserver study investigating the effectiveness of prostatic multiparametric magnetic resonance imaging to dose escalate corresponding histologic lesions using high-dose-rate brachytherapy. | Brachytherapy | 2021 |
| 34589619 | Prostate specific membrane antigen positron emission tomography for lesion-directed high-dose-rate brachytherapy dose escalation. | Phys Imaging Radiat Oncol | 2021 |
| 34408985 | Establishing a Provincial Registry for Recurrent Prostate Cancer: Providing Access to PSMA PET/CT in Ontario, Canada. | Front Oncol | 2021 |
| 34635471 | Implementation and evaluation of an online anatomy, radiology and contouring bootcamp for radiation therapists. | J Med Imaging Radiat Sci | 2021 |
| 34568575 | Development, Implementation, and Initial Participant Feedback of an Online Anatomy and Radiology Contouring Bootcamp in Radiation Oncology. | J Med Educ Curric Dev | 2021 |
| 34652551 | Short-duration dynamic [<sup>18</sup>F]DCFPyL PET and CT perfusion imaging to localize dominant intraprostatic lesions in prostate cancer: validation against digital histopathology and comparison to [<sup>18</sup>F]DCFPyL PET/MR at 120 minutes. | EJNMMI Res | 2021 |
| 34130872 | Re: Rachel M. Glicksman, Ur Metser, Douglass Vines, et al. Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis Hypothesis. Eur Urol 2021;80:374-82. | Eur Urol | 2021 |
| 34151046 | Rapid visual field progression in a patient with glaucoma as the presenting manifestation of sarcoidosis. | Am J Ophthalmol Case Rep | 2021 |
| 33999811 | Case - Prostate-specific antigen bounce: A pitfall in prostate-specific membrane antigen positron emission tomography/computed tomography interpretation. | Can Urol Assoc J | 2021 |
| 34278053 | Can Polymetastatic Disease Be ARRESTed Using SABR? A Dosimetric Feasibility Study to Inform Development of a Phase 1 Trial. | Adv Radiat Oncol | 2021 |
| 33476253 | Prostate-specific membrane antigen targeted PET/CT for recurrent prostate cancer: a clinician's guide. | Expert Rev Anticancer Ther | 2021 |
| 33394284 | Kinetic analysis of dominant intraprostatic lesion of prostate cancer using quantitative dynamic [<sup>18</sup>F]DCFPyL-PET: comparison to [<sup>18</sup>F]fluorocholine-PET. | EJNMMI Res | 2021 |
| 33382375 | Case series - <sup>18</sup>F-DCFPyL-positron emission tomography/computed tomography (PET/CT) time of imaging. | Can Urol Assoc J | 2021 |
| 31300234 | Re: Joaquin Mateo, Karim Fizazi, Silke Gillessen, et al. Managing Nonmetastatic Castration-resistant Prostate Cancer. Eur Urol 2019:75:285-93. | Eur Urol | 2020 |
| 33521396 | Utilization of Salvage and Systemic Therapies for Recurrent Prostate Cancer as a Result of <sup>18</sup>F-DCFPyL PET/CT Restaging. | Adv Radiat Oncol | 2020 |
| 31730876 | A Prospective Study of 18F-DCFPyL PSMA PET/CT Restaging in Recurrent Prostate Cancer following Primary External Beam Radiotherapy or Brachytherapy. | Int J Radiat Oncol Biol Phys | 2020 |
| 31926754 | The Singularity is Near(ish): Emerging Applications of Artificial Intelligence in Prostate Cancer Management. | Eur Urol | 2020 |
| 33260535 | Optimizing PSMA Radioligand Therapy for Patients with Metastatic Castration-Resistant Prostate Cancer. A Systematic Review and Meta-Analysis. | Int J Mol Sci | 2020 |
| 33036579 | Is hypofractionated whole pelvis radiotherapy (WPRT) as well tolerated as conventionally fractionated WPRT in prostate cancer patients? The HOPE trial. | BMC Cancer | 2020 |
| 32717361 | Is prostate brachytherapy a dying art? Trends and variation in the definitive management of prostate cancer in Ontario, Canada. | Radiother Oncol | 2020 |
| 32605858 | Re: Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. | Eur Urol | 2020 |
| 32715024 | Automatic cancer detection on digital histopathology images of mid-gland radical prostatectomy specimens. | J Med Imaging (Bellingham) | 2020 |
| 32827589 | Histologic validation of auto-contoured dominant intraprostatic lesions on [<sup>18</sup>F] DCFPyL PSMA-PET imaging. | Radiother Oncol | 2020 |